id	domain	url
admet-2861	dx.doi.org	http://dx.doi.org/10.5599/admet.2861
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	www.pub.iapchem.org	http://www.pub.iapchem.org/ojs/index.ph-p/admet/index
admet-2861	creativecommons.org	http://creativecommons.org/licenses/by/4.0/)
admet-2861	dx.doi.org	http://dx.doi.org/10.5599/admet.2861
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	www.pub.iapchem.org	http://www.pub.iapchem.org/ojs/index.php/admet/index
admet-2861	creativecommons.org	http://creativecommons.org/licenses/by/4.0
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	pv-systems.pl	https://pv-systems.pl/en/products/copleyscientific/19-inhaler-testing/ancillaries/100-copley-inhaler-testing-data-analysis-software-citdas
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	pv-systems.pl	https://pv-systems.pl/en/products/copley-scientific/19-inhaler-testing/ancillaries/100-copley-inhaler-testing-data-analysis-software-citdas
admet-2861	pv-systems.pl	https://pv-systems.pl/en/products/copley-scientific/19-inhaler-testing/ancillaries/100-copley-inhaler-testing-data-analysis-software-citdas
admet-2861	www.simulations-plus.com	https://www.simulations-plus.com/software/gastroplus/)
admet-2861	www.simulations-plus.com	https://www.simulations-plus.com/software/gastroplus
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	www.ema.europa.eu	https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-pharmaceutical-qualityinhalation-and-nasal-products_en.pdf
admet-2861	www.edqm.eu	https://www.edqm.eu/en/european-pharmacopoeia-ph.-eur.-11th-edition
admet-2861	www.ema.europa.eu	https://www.ema.europa.eu/en/documents/scientificguideline/draft-guideline-pharmaceutical-quality-inhalation-nasal-medicinal-products-revision1_en.pdf
admet-2861	www.researchgate.net	https://www.researchgate.net/publication/237379078_the_inhalation_ad_hoc_advisory_panel_for
admet-2861	www.accessdata.fda.gov	https://www.accessdata.fda.gov/drugsatfda_docs/psg/psg_021929.pdf
admet-2861	www.accessdata.fda.gov	https://www.accessdata.fda.gov/drugsatfda_docs/psg/psg_021433.pdf
admet-2861	doi.org	https://doi.org/10.3390/pharmaceutics15030983
admet-2861	doi.org	https://doi.org/10.3390/pharmaceutics14122667
admet-2861	doi.org	https://doi.org/10.14227/dt170210p6
admet-2861	doi.org	https://doi.org/10.1016/j.jconrel.2005.01.003
admet-2861	doi.org	https://doi.org/10.1002/jps.21653
admet-2861	www.ema.europa.eu	https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-pharmaceutical-quality-inhalation-and-nasal-products_en.pdf
admet-2861	www.ema.europa.eu	https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-pharmaceutical-quality-inhalation-and-nasal-products_en.pdf
admet-2861	www.edqm.eu	https://www.edqm.eu/en/european-pharmacopoeia-ph.-eur.-11th-edition
admet-2861	www.ema.europa.eu	https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-pharmaceutical-quality-inhalation-nasal-medicinal-products-revision-1_en.pdf
admet-2861	www.ema.europa.eu	https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-pharmaceutical-quality-inhalation-nasal-medicinal-products-revision-1_en.pdf
admet-2861	www.ema.europa.eu	https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-pharmaceutical-quality-inhalation-nasal-medicinal-products-revision-1_en.pdf
admet-2861	www.researchgate.net	https://www.researchgate.net/publication/237379078_the_inhalation_ad_hoc_advisory_panel_for_the_usp_performance_tests_of_inhalation_dosage_forms
admet-2861	www.researchgate.net	https://www.researchgate.net/publication/237379078_the_inhalation_ad_hoc_advisory_panel_for_the_usp_performance_tests_of_inhalation_dosage_forms
admet-2861	www.accessdata.fda.gov	https://www.accessdata.fda.gov/drugsatfda_docs/psg/psg_021929.pdf
admet-2861	www.accessdata.fda.gov	https://www.accessdata.fda.gov/drugsatfda_docs/psg/psg_021433.pdf
admet-2861	doi.org	https://doi.org/10.3390/pharmaceutics15030983
admet-2861	doi.org	https://doi.org/10.3390/pharmaceutics14122667
admet-2861	doi.org	https://doi.org/10.14227/dt170210p6
admet-2861	doi.org	https://doi.org/10.1016/j.jconrel.2005.01.003
admet-2861	doi.org	https://doi.org/10.1002/jps.21653
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	doi.org	https://doi.org/10.3390/pharmaceutics13101541
admet-2861	www.mdpi.com	https://www.mdpi.com/1999-4923/16/8/989
admet-2861	doi.org	https://doi.org/10.1021/acs.molpharmaceut.5b00221
admet-2861	doi.org	https://doi.org/10.1007/s11095-010-0070-5
admet-2861	doi.org	https://doi.org/10.1021/acs.molpharmaceut.8b00796
admet-2861	doi.org	https://doi.org/10.1016/s03785173(03)00091-7
admet-2861	doi.org	https://doi.org/10.1081/ddc-100100991
admet-2861	doi.org	https://doi.org/10.1016/j.ijpharm.2009.07.034
admet-2861	doi.org	https://doi.org/10.1007/s11095-012-0744-2
admet-2861	doi.org	https://doi.org/10.1089/adt.2017.779
admet-2861	www.inhalation.se	https://www.inhalation.se/inhalation-researchservices/dissolvit-in-vitro-dissolution
admet-2861	doi.org	https://doi.org/10.1016/j.jaerosci.2020.105698
admet-2861	doi.org	https://doi.org/10.1016/j.ejps.2017.09.002
admet-2861	doi.org	https://doi.org/10.26650/istanbuljpharm.2023.1005069
admet-2861	doi.org	https://doi.org/10.1016/j.ijpharm.2018.11.072
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	doi.org	https://doi.org/10.3390/pharmaceutics13101541
admet-2861	www.mdpi.com	https://www.mdpi.com/1999-4923/16/8/989
admet-2861	doi.org	https://doi.org/10.1021/acs.molpharmaceut.5b00221
admet-2861	doi.org	https://doi.org/10.1007/s11095-010-0070-5
admet-2861	doi.org	https://doi.org/10.1021/acs.molpharmaceut.8b00796
admet-2861	doi.org	https://doi.org/10.1016/s0378-5173(03)00091-7
admet-2861	doi.org	https://doi.org/10.1016/s0378-5173(03)00091-7
admet-2861	doi.org	https://doi.org/10.1081/ddc-100100991
admet-2861	doi.org	https://doi.org/10.1016/j.ijpharm.2009.07.034
admet-2861	doi.org	https://doi.org/10.1007/s11095-012-0744-2
admet-2861	doi.org	https://doi.org/10.1089/adt.2017.779
admet-2861	www.inhalation.se	https://www.inhalation.se/inhalation-research-services/dissolvit-in-vitro-dissolution
admet-2861	www.inhalation.se	https://www.inhalation.se/inhalation-research-services/dissolvit-in-vitro-dissolution
admet-2861	doi.org	https://doi.org/10.1016/j.jaerosci.2020.105698
admet-2861	doi.org	https://doi.org/10.1016/j.ejps.2017.09.002
admet-2861	dx.doi.org	http://dx.doi.org/10.26650/istanbuljpharm.2023.1005069
admet-2861	doi.org	https://doi.org/10.1016/j.ijpharm.2018.11.072
admet-2861	www.researchgate.net	https://www.researchgate.net/publication/333392765_contribution_to_development_of_discrimin
admet-2861	doi.org	https://doi.org/10.1080/10826076.2011.557464
admet-2861	doi.org	https://doi.org/10.1556/achrom.27.2015.2.8
admet-2861	doi.org	https://doi.org/10.1046/j.0306-5251.2001.01374.x
admet-2861	doi.org	https://doi.org/10.1007/978-3-030-73909-6_74
admet-2861	doi.org	https://doi.org/10.1007/s00228-002-0466-1
admet-2861	doi.org	https://doi.org/10.1016/j.pupt.2008.01.001
admet-2861	www.ema.europa.eu	https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-requirements-clinicaldocumentation-orally-inhaled-products-including-requirements-demonstration-therapeuticequivalence-between-two-inhaled-products-use-treatment-asthma-chronic-obstructive_en.pdf
admet-2861	doi.org	https://doi.org/10.1186/s12931-019-0970-9
admet-2861	doi.org	https://doi.org/10.1016/s1095-6433(01)00315-4
admet-2861	doi.org	https://doi.org/10.1007/s00408-004-2511-6
admet-2861	doi.org	https://doi.org/10.1152/nips.01438.2003
admet-2861	doi.org	https://doi.org/10.1080/10408444.2021.1903386
admet-2861	doi.org	https://doi.org/10.1111/j.2042-7158.2012.01523.x
admet-2861	go.drugbank.com	https://go.drugbank.com/drugs/db00394
admet-2861	www.researchgate.net	https://www.researchgate.net/publication/333392765_contribution_to_development_of_discriminative_dissolution_method_for_inhalation_preparations
admet-2861	www.researchgate.net	https://www.researchgate.net/publication/333392765_contribution_to_development_of_discriminative_dissolution_method_for_inhalation_preparations
admet-2861	doi.org	https://doi.org/10.1080/10826076.2011.557464
admet-2861	doi.org	https://doi.org/10.1556/achrom.27.2015.2.8
admet-2861	doi.org	https://doi.org/10.1046/j.0306-5251.2001.01374.x
admet-2861	doi.org	https://doi.org/10.1007/978-3-030-73909-6_74
admet-2861	doi.org	https://doi.org/10.1007/s00228-002-0466-1
admet-2861	doi.org	https://doi.org/10.1016/j.pupt.2008.01.001
admet-2861	www.ema.europa.eu	https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-requirements-clinical-documentation-orally-inhaled-products-including-requirements-demonstration-therapeutic-equivalence-between-two-inhaled-products-use-treatment-asthma-chronic-obstructive_en.pdf
admet-2861	www.ema.europa.eu	https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-requirements-clinical-documentation-orally-inhaled-products-including-requirements-demonstration-therapeutic-equivalence-between-two-inhaled-products-use-treatment-asthma-chronic-obstructive_en.pdf
admet-2861	www.ema.europa.eu	https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-requirements-clinical-documentation-orally-inhaled-products-including-requirements-demonstration-therapeutic-equivalence-between-two-inhaled-products-use-treatment-asthma-chronic-obstructive_en.pdf
admet-2861	doi.org	https://doi.org/10.1186/s12931-019-0970-9
admet-2861	doi.org	https://doi.org/10.1016/s1095-6433(01)00315-4
admet-2861	doi.org	https://doi.org/10.1007/s00408-004-2511-6
admet-2861	doi.org	https://doi.org/10.1152/nips.01438.2003
admet-2861	doi.org	https://doi.org/10.1080/10408444.2021.1903386
admet-2861	doi.org	https://doi.org/10.1111/j.2042-7158.2012.01523.x
admet-2861	go.drugbank.com	https://go.drugbank.com/drugs/db00394
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	doi.org	https://doi.org/10.1208/s12249-012-9822-3
admet-2861	doi.org	https://doi.org/10.1016/j.ijpharm.2018.04.048
admet-2861	doi.org	https://doi.org/10.1056/nejmra0910061
admet-2861	doi.org	https://doi.org/10.1155/2015/571816
admet-2861	doi.org	https://doi.org/10.1111/j.2042-7158.2011.01398.x
admet-2861	doi.org	https://doi.org/10.1016/j.rmed.2017.09.012
admet-2861	doi.org	https://doi.org/10.1016/j.ijpharm.2006.01.018
admet-2861	doi.org	https://doi.org/10.1016/j.powtec.2010.11.012
admet-2861	link.oversea.cnki.net	https://link.oversea.cnki.net/doi/10.14135/j.cnki.1006-3080.20200328001
admet-2861	doi.org	https://doi.org/10.1002/jps.2600650611
admet-2861	doi.org	https://doi.org/10.1016/j.ejpb.2017.11.013
admet-2861	doi.org	https://doi.org/10.1186/1465-9921-7-10
admet-2861	doi.org	https://doi.org/10.1208/s12248-020-0422-y
admet-2861	go.drugbank.com	https://go.drugbank.com/drugs/db14221
admet-2861	pubchem.ncbi.nlm.nih.gov	https://pubchem.ncbi.nlm.nih.gov/compound/beclomethasonedipropionate
admet-2861	doi.org	https://doi.org/10.1016/s09546111(98)90434-6
admet-2861	doi.org	https://doi.org/10.4155/tde.11.19
admet-2861	doi.org	https://doi.org/10.5599/admet.2861
admet-2861	doi.org	https://doi.org/10.1208/s12249-012-9822-3
admet-2861	doi.org	https://doi.org/10.1016/j.ijpharm.2018.04.048
admet-2861	doi.org	https://doi.org/10.1056/nejmra0910061
admet-2861	doi.org	https://doi.org/10.1155/2015/571816
admet-2861	doi.org	https://doi.org/10.1111/j.2042-7158.2011.01398.x
admet-2861	doi.org	https://doi.org/10.1016/j.rmed.2017.09.012
admet-2861	doi.org	https://doi.org/10.1016/j.ijpharm.2006.01.018
admet-2861	doi.org	https://doi.org/10.1016/j.powtec.2010.11.012
admet-2861	link.oversea.cnki.net	https://link.oversea.cnki.net/doi/10.14135/j.cnki.1006-3080.20200328001
admet-2861	doi.org	https://doi.org/10.1002/jps.2600650611
admet-2861	doi.org	https://doi.org/10.1016/j.ejpb.2017.11.013
admet-2861	doi.org	https://doi.org/10.1186/1465-9921-7-10
admet-2861	doi.org	https://doi.org/10.1208/s12248-020-0422-y
admet-2861	go.drugbank.com	https://go.drugbank.com/drugs/db14221
admet-2861	pubchem.ncbi.nlm.nih.gov	https://pubchem.ncbi.nlm.nih.gov/compound/beclomethasone-dipropionate
admet-2861	pubchem.ncbi.nlm.nih.gov	https://pubchem.ncbi.nlm.nih.gov/compound/beclomethasone-dipropionate
admet-2861	doi.org	https://doi.org/10.1016/s0954-6111(98)90434-6
admet-2861	doi.org	https://doi.org/10.1016/s0954-6111(98)90434-6
admet-2861	doi.org	https://doi.org/10.4155/tde.11.19
admet-2861	sites.ualberta.ca	https://sites.ualberta.ca/~csps/jpps1(3)/h.boxenbaum/flipflop.htm
admet-2861	doi.org	https://doi.org/10.1016/b978-0-323-44329-6.00002-4
admet-2861	doi.org	https://doi.org/10.1002/j.1552-4604.1997.tb04262.x
admet-2861	doi.org	https://doi.org/10.1021/acs.molpharmaceut.3c00685
admet-2861	creativecommons.org	http://creativecommons.org/licenses/by/3.0/
admet-2861	sites.ualberta.ca	https://sites.ualberta.ca/~csps/jpps1(3)/h.boxenbaum/flip-flop.htm
admet-2861	sites.ualberta.ca	https://sites.ualberta.ca/~csps/jpps1(3)/h.boxenbaum/flip-flop.htm
admet-2861	doi.org	https://doi.org/10.1016/b978-0-323-44329-6.00002-4
admet-2861	doi.org	https://doi.org/10.1002/j.1552-4604.1997.tb04262.x
admet-2861	doi.org	https://doi.org/10.1021/acs.molpharmaceut.3c00685
admet-2861	creativecommons.org	http://creativecommons.org/licenses/by/3.0